GRAL vs TECH · rev $125.6M vs P/E 65, rev $1.22B
GRAIL, LLC (GRAL) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
GRAIL, LLC (GRAL) is a diagnostics & research company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported GRAL revenue for 2024-12-31 was $125.6M. Net income was -$2.03B. Revenue was up 34.9% from 2023-12-31 to 2024-12-31. GRAL currently screens at market cap $2.57B.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
GRAL currently screens at market cap $2.57B. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the GRAL and TECH stock pages for the full models.
Not investment advice.